Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients
- Conditions
- DiabetesCoronaropathy
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Alvimedica Medical Technologies France
- Target Recruit Count
- 1030
- Registration Number
- NCT03842813
- Locations
- 🇫🇷
Centre Hospitalier Pau, Pau, France
🇫🇷Hôpital Simone Veil, Eaubonne, France
🇫🇷Centre Hospitalier Gonesse, Gonesse, France
© Copyright 2025. All Rights Reserved by MedPath